# Jeffrey R. Hoodin, M.D. – FDA Inspection, Mar 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/jeffrey-r-hoodin-md/3ff9a2f0-f714-40d0-b957-2fedeb3f81e8
Source feed: FDA_Inspections

> FDA inspection 1307264 of Jeffrey R. Hoodin, M.D., March 13, 2026. 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1307264
- Company Name: Jeffrey R. Hoodin, M.D.
- Inspection Date: 2026-03-13
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Denver District Office
- Citation Count: 2

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/andra-lepnis/38811302-3d96-427a-955d-c4c42de05a7c)
- [Investigator](https://www.keypedia.com/people/lan-t-tran/ab9c1008-c03f-425f-ac3c-a569d3e5037c)

Company: https://www.keypedia.com/companies/jeffrey-r-hoodin-md/71a8d83c-0100-41ac-82c6-e476d24789c1

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face
